Loading…

Drug‐Induced Hypersensitivity Syndrome Associated with Human Herpesvirus 6 and Cytomegalovirus Reactivation

We describe a patient with drug‐induced hypersensitivity syndrome (DIHS) associated with human herpesvirus 6 (HHV‐6) and cytomegalovirus (CMV) infection induced by sulfasalazine. Two weeks after starting sulfasalazine to treat a rectal ulcer, the patient developed disseminated macular erythema accom...

Full description

Saved in:
Bibliographic Details
Published in:Journal of dermatology 2005-12, Vol.32 (12), p.976-981
Main Authors: Komura, Kazuhiro, Hasegawa, Minoru, Hamaguchi, Yasuhito, Yukami, Toru, Nagai, Masaki, Yachie, Akihiro, Sato, Shinichi, Takehara, Kazuhiko
Format: Article
Language:English
Subjects:
Citations: Items that this one cites
Items that cite this one
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
cited_by cdi_FETCH-LOGICAL-c4605-c3fd5623dec3a28fedff1f2dd4a3d7bb3f275b13d0fb8d2c199cf1b5c4f621ac3
cites cdi_FETCH-LOGICAL-c4605-c3fd5623dec3a28fedff1f2dd4a3d7bb3f275b13d0fb8d2c199cf1b5c4f621ac3
container_end_page 981
container_issue 12
container_start_page 976
container_title Journal of dermatology
container_volume 32
creator Komura, Kazuhiro
Hasegawa, Minoru
Hamaguchi, Yasuhito
Yukami, Toru
Nagai, Masaki
Yachie, Akihiro
Sato, Shinichi
Takehara, Kazuhiko
description We describe a patient with drug‐induced hypersensitivity syndrome (DIHS) associated with human herpesvirus 6 (HHV‐6) and cytomegalovirus (CMV) infection induced by sulfasalazine. Two weeks after starting sulfasalazine to treat a rectal ulcer, the patient developed disseminated macular erythema accompanied by fever, liver injury, and lymphadenopathy. Seroconversion of antibodies to HHV‐6 was observed. Systemic steroid treatment was not effective against the eruptions. Five months after the onset, he presented with an acute febrile disease. The detection of CMV antigen on peripheral blood leukocytes and positive staining for CMV on cutaneous endothelium indicated active CMV infection. Furthermore, he developed a bacteremia of methicillin resistant Staphylococcus aureus. An associatiation the CMV reactivation with DIHS was suggested, although there remains the possibility that the systemic steroid treatment precipitated CMV reactivation. Recently, HHV‐6 has been documented to have immunomodulating effects and to be associated with CMV reactivation. Therefore, we should pay attention to the possibility of CMV reactivation in patients with DIHS in whom the immunomodulating virus of HHV‐6 has been reactivated.
doi_str_mv 10.1111/j.1346-8138.2005.tb00885.x
format article
fullrecord <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_1566856934</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>1566856934</sourcerecordid><originalsourceid>FETCH-LOGICAL-c4605-c3fd5623dec3a28fedff1f2dd4a3d7bb3f275b13d0fb8d2c199cf1b5c4f621ac3</originalsourceid><addsrcrecordid>eNqVkMtOAjEUhhujEURfwUxcuZmxl2kZXGkABUNi4mXddHrBkrlgOwPMzkfwGX0SByG6tps253z_3-QD4ALBCLXnahEhErMwQSSJMIQ0qlIIk4RGmwPQ_V0dgi4kCQ1xDPsdcOL9AkI8oAgegw5icR_FDHVBPnL1_Ovjc1qoWmoVTJqldl4X3lZ2ZasmeG4K5cpcB7fel9KKqoXWtnoLJnUuimCi3VL7lXW1D1ggChUMm6rF5yIrd9MnLWTbJSpbFqfgyIjM67P93QOvd-OX4SScPd5Ph7ezUMYM0lASoyjDRGlJBE6MVsYgg5WKBVH9NCUG92mKiIImTRSWaDCQBqVUxoZhJCTpgctd79KV77X2Fc-tlzrLRKHL2nNEGUsoG5C4Ra93qHSl904bvnQ2F67hCPKtbr7gW6d865RvdfO9br5pw-f7f-o01-ovuvfbAjc7YG0z3fyjmj-Mxj9P8g3pJJS9</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>1566856934</pqid></control><display><type>article</type><title>Drug‐Induced Hypersensitivity Syndrome Associated with Human Herpesvirus 6 and Cytomegalovirus Reactivation</title><source>Wiley-Blackwell Read &amp; Publish Collection</source><creator>Komura, Kazuhiro ; Hasegawa, Minoru ; Hamaguchi, Yasuhito ; Yukami, Toru ; Nagai, Masaki ; Yachie, Akihiro ; Sato, Shinichi ; Takehara, Kazuhiko</creator><creatorcontrib>Komura, Kazuhiro ; Hasegawa, Minoru ; Hamaguchi, Yasuhito ; Yukami, Toru ; Nagai, Masaki ; Yachie, Akihiro ; Sato, Shinichi ; Takehara, Kazuhiko</creatorcontrib><description>We describe a patient with drug‐induced hypersensitivity syndrome (DIHS) associated with human herpesvirus 6 (HHV‐6) and cytomegalovirus (CMV) infection induced by sulfasalazine. Two weeks after starting sulfasalazine to treat a rectal ulcer, the patient developed disseminated macular erythema accompanied by fever, liver injury, and lymphadenopathy. Seroconversion of antibodies to HHV‐6 was observed. Systemic steroid treatment was not effective against the eruptions. Five months after the onset, he presented with an acute febrile disease. The detection of CMV antigen on peripheral blood leukocytes and positive staining for CMV on cutaneous endothelium indicated active CMV infection. Furthermore, he developed a bacteremia of methicillin resistant Staphylococcus aureus. An associatiation the CMV reactivation with DIHS was suggested, although there remains the possibility that the systemic steroid treatment precipitated CMV reactivation. Recently, HHV‐6 has been documented to have immunomodulating effects and to be associated with CMV reactivation. Therefore, we should pay attention to the possibility of CMV reactivation in patients with DIHS in whom the immunomodulating virus of HHV‐6 has been reactivated.</description><identifier>ISSN: 0385-2407</identifier><identifier>EISSN: 1346-8138</identifier><identifier>DOI: 10.1111/j.1346-8138.2005.tb00885.x</identifier><identifier>PMID: 16471461</identifier><language>eng</language><publisher>England</publisher><subject>Aged ; Cytomegalovirus ; Cytomegalovirus - physiology ; Cytomegalovirus Infections - diagnosis ; Cytomegalovirus Infections - pathology ; Drug Hypersensitivity - etiology ; Drug Hypersensitivity - pathology ; drug‐induced hypersensitivity syndrome ; Exanthema Subitum - chemically induced ; Exanthema Subitum - pathology ; Facial Dermatoses - chemically induced ; Facial Dermatoses - pathology ; Follow-Up Studies ; Herpesvirus 6, Human - physiology ; Human cytomegalovirus ; Human herpesvirus 6 ; Humans ; immunodeficiency ; Male ; Patch Tests ; Risk Assessment ; Severity of Illness Index ; Staphylococcus aureus ; sulfasalazine ; Sulfasalazine - adverse effects ; Sulfasalazine - therapeutic use ; Syndrome ; Virus Activation</subject><ispartof>Journal of dermatology, 2005-12, Vol.32 (12), p.976-981</ispartof><rights>2005 Japanese Dermatological Association</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c4605-c3fd5623dec3a28fedff1f2dd4a3d7bb3f275b13d0fb8d2c199cf1b5c4f621ac3</citedby><cites>FETCH-LOGICAL-c4605-c3fd5623dec3a28fedff1f2dd4a3d7bb3f275b13d0fb8d2c199cf1b5c4f621ac3</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>314,780,784,27924,27925</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/16471461$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Komura, Kazuhiro</creatorcontrib><creatorcontrib>Hasegawa, Minoru</creatorcontrib><creatorcontrib>Hamaguchi, Yasuhito</creatorcontrib><creatorcontrib>Yukami, Toru</creatorcontrib><creatorcontrib>Nagai, Masaki</creatorcontrib><creatorcontrib>Yachie, Akihiro</creatorcontrib><creatorcontrib>Sato, Shinichi</creatorcontrib><creatorcontrib>Takehara, Kazuhiko</creatorcontrib><title>Drug‐Induced Hypersensitivity Syndrome Associated with Human Herpesvirus 6 and Cytomegalovirus Reactivation</title><title>Journal of dermatology</title><addtitle>J Dermatol</addtitle><description>We describe a patient with drug‐induced hypersensitivity syndrome (DIHS) associated with human herpesvirus 6 (HHV‐6) and cytomegalovirus (CMV) infection induced by sulfasalazine. Two weeks after starting sulfasalazine to treat a rectal ulcer, the patient developed disseminated macular erythema accompanied by fever, liver injury, and lymphadenopathy. Seroconversion of antibodies to HHV‐6 was observed. Systemic steroid treatment was not effective against the eruptions. Five months after the onset, he presented with an acute febrile disease. The detection of CMV antigen on peripheral blood leukocytes and positive staining for CMV on cutaneous endothelium indicated active CMV infection. Furthermore, he developed a bacteremia of methicillin resistant Staphylococcus aureus. An associatiation the CMV reactivation with DIHS was suggested, although there remains the possibility that the systemic steroid treatment precipitated CMV reactivation. Recently, HHV‐6 has been documented to have immunomodulating effects and to be associated with CMV reactivation. Therefore, we should pay attention to the possibility of CMV reactivation in patients with DIHS in whom the immunomodulating virus of HHV‐6 has been reactivated.</description><subject>Aged</subject><subject>Cytomegalovirus</subject><subject>Cytomegalovirus - physiology</subject><subject>Cytomegalovirus Infections - diagnosis</subject><subject>Cytomegalovirus Infections - pathology</subject><subject>Drug Hypersensitivity - etiology</subject><subject>Drug Hypersensitivity - pathology</subject><subject>drug‐induced hypersensitivity syndrome</subject><subject>Exanthema Subitum - chemically induced</subject><subject>Exanthema Subitum - pathology</subject><subject>Facial Dermatoses - chemically induced</subject><subject>Facial Dermatoses - pathology</subject><subject>Follow-Up Studies</subject><subject>Herpesvirus 6, Human - physiology</subject><subject>Human cytomegalovirus</subject><subject>Human herpesvirus 6</subject><subject>Humans</subject><subject>immunodeficiency</subject><subject>Male</subject><subject>Patch Tests</subject><subject>Risk Assessment</subject><subject>Severity of Illness Index</subject><subject>Staphylococcus aureus</subject><subject>sulfasalazine</subject><subject>Sulfasalazine - adverse effects</subject><subject>Sulfasalazine - therapeutic use</subject><subject>Syndrome</subject><subject>Virus Activation</subject><issn>0385-2407</issn><issn>1346-8138</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2005</creationdate><recordtype>article</recordtype><recordid>eNqVkMtOAjEUhhujEURfwUxcuZmxl2kZXGkABUNi4mXddHrBkrlgOwPMzkfwGX0SByG6tps253z_3-QD4ALBCLXnahEhErMwQSSJMIQ0qlIIk4RGmwPQ_V0dgi4kCQ1xDPsdcOL9AkI8oAgegw5icR_FDHVBPnL1_Ovjc1qoWmoVTJqldl4X3lZ2ZasmeG4K5cpcB7fel9KKqoXWtnoLJnUuimCi3VL7lXW1D1ggChUMm6rF5yIrd9MnLWTbJSpbFqfgyIjM67P93QOvd-OX4SScPd5Ph7ezUMYM0lASoyjDRGlJBE6MVsYgg5WKBVH9NCUG92mKiIImTRSWaDCQBqVUxoZhJCTpgctd79KV77X2Fc-tlzrLRKHL2nNEGUsoG5C4Ra93qHSl904bvnQ2F67hCPKtbr7gW6d865RvdfO9br5pw-f7f-o01-ovuvfbAjc7YG0z3fyjmj-Mxj9P8g3pJJS9</recordid><startdate>200512</startdate><enddate>200512</enddate><creator>Komura, Kazuhiro</creator><creator>Hasegawa, Minoru</creator><creator>Hamaguchi, Yasuhito</creator><creator>Yukami, Toru</creator><creator>Nagai, Masaki</creator><creator>Yachie, Akihiro</creator><creator>Sato, Shinichi</creator><creator>Takehara, Kazuhiko</creator><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7T5</scope><scope>7U9</scope><scope>H94</scope></search><sort><creationdate>200512</creationdate><title>Drug‐Induced Hypersensitivity Syndrome Associated with Human Herpesvirus 6 and Cytomegalovirus Reactivation</title><author>Komura, Kazuhiro ; Hasegawa, Minoru ; Hamaguchi, Yasuhito ; Yukami, Toru ; Nagai, Masaki ; Yachie, Akihiro ; Sato, Shinichi ; Takehara, Kazuhiko</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c4605-c3fd5623dec3a28fedff1f2dd4a3d7bb3f275b13d0fb8d2c199cf1b5c4f621ac3</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2005</creationdate><topic>Aged</topic><topic>Cytomegalovirus</topic><topic>Cytomegalovirus - physiology</topic><topic>Cytomegalovirus Infections - diagnosis</topic><topic>Cytomegalovirus Infections - pathology</topic><topic>Drug Hypersensitivity - etiology</topic><topic>Drug Hypersensitivity - pathology</topic><topic>drug‐induced hypersensitivity syndrome</topic><topic>Exanthema Subitum - chemically induced</topic><topic>Exanthema Subitum - pathology</topic><topic>Facial Dermatoses - chemically induced</topic><topic>Facial Dermatoses - pathology</topic><topic>Follow-Up Studies</topic><topic>Herpesvirus 6, Human - physiology</topic><topic>Human cytomegalovirus</topic><topic>Human herpesvirus 6</topic><topic>Humans</topic><topic>immunodeficiency</topic><topic>Male</topic><topic>Patch Tests</topic><topic>Risk Assessment</topic><topic>Severity of Illness Index</topic><topic>Staphylococcus aureus</topic><topic>sulfasalazine</topic><topic>Sulfasalazine - adverse effects</topic><topic>Sulfasalazine - therapeutic use</topic><topic>Syndrome</topic><topic>Virus Activation</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Komura, Kazuhiro</creatorcontrib><creatorcontrib>Hasegawa, Minoru</creatorcontrib><creatorcontrib>Hamaguchi, Yasuhito</creatorcontrib><creatorcontrib>Yukami, Toru</creatorcontrib><creatorcontrib>Nagai, Masaki</creatorcontrib><creatorcontrib>Yachie, Akihiro</creatorcontrib><creatorcontrib>Sato, Shinichi</creatorcontrib><creatorcontrib>Takehara, Kazuhiko</creatorcontrib><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>Immunology Abstracts</collection><collection>Virology and AIDS Abstracts</collection><collection>AIDS and Cancer Research Abstracts</collection><jtitle>Journal of dermatology</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Komura, Kazuhiro</au><au>Hasegawa, Minoru</au><au>Hamaguchi, Yasuhito</au><au>Yukami, Toru</au><au>Nagai, Masaki</au><au>Yachie, Akihiro</au><au>Sato, Shinichi</au><au>Takehara, Kazuhiko</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Drug‐Induced Hypersensitivity Syndrome Associated with Human Herpesvirus 6 and Cytomegalovirus Reactivation</atitle><jtitle>Journal of dermatology</jtitle><addtitle>J Dermatol</addtitle><date>2005-12</date><risdate>2005</risdate><volume>32</volume><issue>12</issue><spage>976</spage><epage>981</epage><pages>976-981</pages><issn>0385-2407</issn><eissn>1346-8138</eissn><abstract>We describe a patient with drug‐induced hypersensitivity syndrome (DIHS) associated with human herpesvirus 6 (HHV‐6) and cytomegalovirus (CMV) infection induced by sulfasalazine. Two weeks after starting sulfasalazine to treat a rectal ulcer, the patient developed disseminated macular erythema accompanied by fever, liver injury, and lymphadenopathy. Seroconversion of antibodies to HHV‐6 was observed. Systemic steroid treatment was not effective against the eruptions. Five months after the onset, he presented with an acute febrile disease. The detection of CMV antigen on peripheral blood leukocytes and positive staining for CMV on cutaneous endothelium indicated active CMV infection. Furthermore, he developed a bacteremia of methicillin resistant Staphylococcus aureus. An associatiation the CMV reactivation with DIHS was suggested, although there remains the possibility that the systemic steroid treatment precipitated CMV reactivation. Recently, HHV‐6 has been documented to have immunomodulating effects and to be associated with CMV reactivation. Therefore, we should pay attention to the possibility of CMV reactivation in patients with DIHS in whom the immunomodulating virus of HHV‐6 has been reactivated.</abstract><cop>England</cop><pmid>16471461</pmid><doi>10.1111/j.1346-8138.2005.tb00885.x</doi><tpages>6</tpages></addata></record>
fulltext fulltext
identifier ISSN: 0385-2407
ispartof Journal of dermatology, 2005-12, Vol.32 (12), p.976-981
issn 0385-2407
1346-8138
language eng
recordid cdi_proquest_miscellaneous_1566856934
source Wiley-Blackwell Read & Publish Collection
subjects Aged
Cytomegalovirus
Cytomegalovirus - physiology
Cytomegalovirus Infections - diagnosis
Cytomegalovirus Infections - pathology
Drug Hypersensitivity - etiology
Drug Hypersensitivity - pathology
drug‐induced hypersensitivity syndrome
Exanthema Subitum - chemically induced
Exanthema Subitum - pathology
Facial Dermatoses - chemically induced
Facial Dermatoses - pathology
Follow-Up Studies
Herpesvirus 6, Human - physiology
Human cytomegalovirus
Human herpesvirus 6
Humans
immunodeficiency
Male
Patch Tests
Risk Assessment
Severity of Illness Index
Staphylococcus aureus
sulfasalazine
Sulfasalazine - adverse effects
Sulfasalazine - therapeutic use
Syndrome
Virus Activation
title Drug‐Induced Hypersensitivity Syndrome Associated with Human Herpesvirus 6 and Cytomegalovirus Reactivation
url http://sfxeu10.hosted.exlibrisgroup.com/loughborough?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2024-12-25T22%3A01%3A13IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Drug%E2%80%90Induced%20Hypersensitivity%20Syndrome%20Associated%20with%20Human%20Herpesvirus%206%20and%20Cytomegalovirus%20Reactivation&rft.jtitle=Journal%20of%20dermatology&rft.au=Komura,%20Kazuhiro&rft.date=2005-12&rft.volume=32&rft.issue=12&rft.spage=976&rft.epage=981&rft.pages=976-981&rft.issn=0385-2407&rft.eissn=1346-8138&rft_id=info:doi/10.1111/j.1346-8138.2005.tb00885.x&rft_dat=%3Cproquest_cross%3E1566856934%3C/proquest_cross%3E%3Cgrp_id%3Ecdi_FETCH-LOGICAL-c4605-c3fd5623dec3a28fedff1f2dd4a3d7bb3f275b13d0fb8d2c199cf1b5c4f621ac3%3C/grp_id%3E%3Coa%3E%3C/oa%3E%3Curl%3E%3C/url%3E&rft_id=info:oai/&rft_pqid=1566856934&rft_id=info:pmid/16471461&rfr_iscdi=true